上海医药集团股份有限公司关于拟收购上海和黄药业有限公司10%股权暨成为实际控制人交易完成的公告

Group 1 - The company Shanghai Pharmaceuticals Holding Co., Ltd. plans to acquire a 10% stake in Shanghai Hutchison Pharmaceuticals Co., Ltd., which will result in the company becoming the actual controller of the target company [2][4] - The acquisition involves a total investment of approximately RMB 995.0366 million, with the company aiming to hold a total of 60% equity in Shanghai Hutchison Pharmaceuticals after the transaction [2][4] - The transaction has been approved by the company's board and is set to be completed by April 25, 2025, with the necessary delivery procedures finalized [4] Group 2 - The company has entered into agreements with Shanghai Jinpu Jianfu Equity Investment Management Co., Ltd. to facilitate the acquisition of shares from Hutchison Whampoa (Hong Kong) Limited [3] - The agreements specify that Shanghai Jinpu Jianfu will acquire 25.1247% of the shares, while another entity will acquire 9.8753% of the shares from Hutchison Whampoa [3]